| Sahil Goyal, MD | |
|
267 Grant St, Bridgeport, CT 06610-2805 | |
| (203) 384-4677 | |
| (203) 384-3135 |
| Full Name | Sahil Goyal |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 11 Years |
| Location | 267 Grant St, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376963355 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Constellation Hospice | Orange, CT | Hospice |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.
Boulder researchers are embarking on a new project to study the progression of neurodegenerative diseases like Alzheimer's by using a new technique to measure neurons firing deep inside animal brains.
ARIUS Research Inc has announced that the Company has initiated the first study in the formal pre-clinical toxicology program for its lead anti-CD44 drug candidate, which is under development for the treatment of breast, prostate and liver cancers.
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.
Boulder researchers are embarking on a new project to study the progression of neurodegenerative diseases like Alzheimer's by using a new technique to measure neurons firing deep inside animal brains.
ARIUS Research Inc has announced that the Company has initiated the first study in the formal pre-clinical toxicology program for its lead anti-CD44 drug candidate, which is under development for the treatment of breast, prostate and liver cancers.
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sahil Goyal, MD 20 York Street, Cb-329, New Haven, CT 06510-3220 Ph: (203) 688-1734 | Sahil Goyal, MD 267 Grant St, Bridgeport, CT 06610-2805 Ph: (203) 384-4677 |
News Archive
New research led by Devang K. Sanghavi of the Mayo Clinic in Florida, USA, suggests pre-intubation use of nitric oxide for patients with COVID-19–related hypoxemic respiratory may help reduce patients' mortality. Their findings show that inhaling nitric oxide in this patient population could reduce the need for future intubation and other invasive mechanical ventilation.
Boulder researchers are embarking on a new project to study the progression of neurodegenerative diseases like Alzheimer's by using a new technique to measure neurons firing deep inside animal brains.
ARIUS Research Inc has announced that the Company has initiated the first study in the formal pre-clinical toxicology program for its lead anti-CD44 drug candidate, which is under development for the treatment of breast, prostate and liver cancers.
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
› Verified 2 days ago
Dr. Arun Chakravarthy Nachiappan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Bridgeport, CT 06610 Phone: 281-797-2850 | |
Evgeny Shkolnik, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 267 Grant Street, Bridgeport Hospital Internal Medicine Residency Program, Bridgeport, CT 06610 Phone: 203-384-3792 Fax: 203-384-4294 | |
Frances Denu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 267 Grant Street, Bridgeport, CT 06610 Phone: 203-384-4677 Fax: 203-384-3135 | |
Nathan A Selsky, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-6000 | |
Emad Alahiri, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 267 Grant Street, Bridgeport, CT 06610 Phone: 203-384-4677 Fax: 203-384-3135 | |
Dr. William Cheuk, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 267 Grant St, Hospitalist Department, Bridgeport, CT 06610 Phone: 203-384-4677 Fax: 203-384-3135 | |
Dr. Jenifer Khan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2800 Main St, Bridgeport, CT 06606 Phone: 203-576-5000 |